ProCE Banner Activity

Treating the Whole Patient: Understanding Needs of Patients With HR+/HER2- MBC and Comorbidities

Slideset

Downloadable slideset on the current treatment landscape, current guidelines for the use of CDK4/6 inhibitors, and available real-world data on risk factors and clinical complexities surrounding the management of patients with HR-positive/HER2-negative metastatic breast cancer with preexisting comorbid conditions.

Released: March 05, 2025

Expiration: March 04, 2026

Share

Provided by

Provided by Clinical Care Options, LLC., in partnership with Practicing Clinicians Exchange (PCE) and ProCE, LLC.

ProCE Banner

Supporters

Supported by an educational grant from Pfizer Inc.

Pfizer Inc.

Partners

Practicing Clinicians Exchange

ProCE Banner

ProCE, LLC

ProCE Banner